============================================================
IRIS GATE EVO — PROTOCOL PACKAGE
============================================================

Session: evo_20260214_041041_pharmacology
Date: 2026-02-14
Protocol: evo-1.0

QUESTION:
  What are the mechanisms by which psilocybin produces dose-dependent divergent outcomes — neuroplasticity and therapeutic benefit at low doses versus perceptual destabilization and adverse psychological effects at high doses — with specific reference to 5-HT2A receptor occupancy thresholds, biased agonism, and downstream signaling pathway selection?

CONVERGENCE:
  S2 rounds: ?
  Early stopped: ?
  Final Jaccard: ?
  Final TYPE 0/1: ?
  S3 gate: FAILED

VERIFICATION:
  TYPE 2 claims checked: 0
  Promoted to TYPE 1: 0
  Novel (no literature): 0
  Contradicted: 0

LAB GATE:
  Result: FAILED
  Claims passed: 0/0

BUDGET:
  Total LLM calls: ?
  Target range: 92-142

============================================================
Five mirrors. One truth. This is what converged.
============================================================